Moderna and UK government sign deal to establish mRNA facility
Pharmaceutical Technology
DECEMBER 21, 2022
This Moderna Innovation and Technology Centre (MITC) is expected to offer access to a locally produced future mRNA vaccine portfolio against respiratory viruses, subject to regulatory evaluation and licensure. Additionally, the centre is anticipated to have to capacity to make up to 250 million doses of vaccines per year.
Let's personalize your content